questionsmedicales.fr
Phénomènes physiologiques
Phénomènes pharmacologiques et toxicologiques
Phénomènes pharmacologiques
Résistance aux substances
Multirésistance aux médicaments
Multirésistance aux médicaments : Questions médicales fréquentes
Diagnostic
5
Résistance aux médicaments
Tests de sensibilité
Tests de sensibilité
Antibiotiques
Infections
Résistance aux médicaments
Antibiogramme
Résistance aux médicaments
Symptômes
5
Infections graves
Symptômes
Infections
Urgences médicales
Prévention
5
Hygiène
Transmission des infections
Vaccins
Prévention des infections
Contrôle des infections
Isolement
Éducation des patients
Antibiotiques
Traitements
5
Antibiotiques
Traitements
Antibiotiques
Thérapies ciblées
Agents pathogènes
Résistance aux médicaments
Prévention
Traitements prophylactiques
Complications
5
Complications
Santé chronique
Soins intensifs
Traitements spécialisés
Facteurs de risque
5
Facteurs de risque
Antibiotiques
Soins à domicile
Résistance aux médicaments
Voyages
Souches résistantes
Maladies chroniques
Infections
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Multirésistance aux médicaments : Questions médicales les plus fréquentes",
"headline": "Multirésistance aux médicaments : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Multirésistance aux médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2026-01-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Multirésistance aux médicaments"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Résistance aux substances",
"url": "https://questionsmedicales.fr/mesh/D004351",
"about": {
"@type": "MedicalCondition",
"name": "Résistance aux substances",
"code": {
"@type": "MedicalCode",
"code": "D004351",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G07.690.773.984"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Multirésistance bactérienne aux médicaments",
"alternateName": "Drug Resistance, Multiple, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D024901",
"about": {
"@type": "MedicalCondition",
"name": "Multirésistance bactérienne aux médicaments",
"code": {
"@type": "MedicalCode",
"code": "D024901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G07.690.773.984.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Multirésistance des champignons aux médicaments",
"alternateName": "Drug Resistance, Multiple, Fungal",
"url": "https://questionsmedicales.fr/mesh/D026141",
"about": {
"@type": "MedicalCondition",
"name": "Multirésistance des champignons aux médicaments",
"code": {
"@type": "MedicalCode",
"code": "D026141",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G07.690.773.984.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Multirésistance virale aux médicaments",
"alternateName": "Drug Resistance, Multiple, Viral",
"url": "https://questionsmedicales.fr/mesh/D024921",
"about": {
"@type": "MedicalCondition",
"name": "Multirésistance virale aux médicaments",
"code": {
"@type": "MedicalCode",
"code": "D024921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G07.690.773.984.300.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Multirésistance aux médicaments",
"alternateName": "Drug Resistance, Multiple",
"code": {
"@type": "MedicalCode",
"code": "D018432",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chunyan Sun",
"url": "https://questionsmedicales.fr/author/Chunyan%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."
}
},
{
"@type": "Person",
"name": "Yu Hu",
"url": "https://questionsmedicales.fr/author/Yu%20Hu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."
}
},
{
"@type": "Person",
"name": "Pablo D Jimenez Castro",
"url": "https://questionsmedicales.fr/author/Pablo%20D%20Jimenez%20Castro",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA; Grupo de Parasitología Veterinaria, Universidad Nacional de Colombia, Colombia. Electronic address: pdj38559@uga.edu."
}
},
{
"@type": "Person",
"name": "John S Gilleard",
"url": "https://questionsmedicales.fr/author/John%20S%20Gilleard",
"affiliation": {
"@type": "Organization",
"name": "Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions Program, University of Calgary, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Ray M Kaplan",
"url": "https://questionsmedicales.fr/author/Ray%20M%20Kaplan",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37971566",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-023-08867-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sub-microscopic Plasmodium falciparum infections and multiple drug resistant single nucleotide polymorphic alleles in pregnant women from southwestern Nigeria.",
"datePublished": "2024-05-09",
"url": "https://questionsmedicales.fr/article/38725016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-024-06763-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "IMB5036 overcomes resistance to multiple chemotherapeutic drugs in human cancer cells through pyroptosis by targeting the KH-type splicing regulatory protein.",
"datePublished": "2023-07-13",
"url": "https://questionsmedicales.fr/article/37451400",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.lfs.2023.121941"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modeling spatial evolution of multi-drug resistance under drug environmental gradients.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38820350",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pcbi.1012098"
}
},
{
"@type": "ScholarlyArticle",
"name": "Circulating biosignatures in multiple myeloma and their role in multidrug resistance.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37120508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12943-022-01683-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques",
"item": "https://questionsmedicales.fr/mesh/D010829"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes pharmacologiques et toxicologiques",
"item": "https://questionsmedicales.fr/mesh/D002620"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phénomènes pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D000069437"
},
{
"@type": "ListItem",
"position": 5,
"name": "Résistance aux substances",
"item": "https://questionsmedicales.fr/mesh/D004351"
},
{
"@type": "ListItem",
"position": 6,
"name": "Multirésistance aux médicaments",
"item": "https://questionsmedicales.fr/mesh/D018432"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Multirésistance aux médicaments - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Multirésistance aux médicaments",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Multirésistance aux médicaments",
"description": "Comment diagnostiquer la multirésistance ?\nQuels tests sont utilisés pour la résistance ?\nQuels signes indiquent une multirésistance ?\nPeut-on identifier les souches résistantes ?\nQuel rôle joue l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Multirésistance aux médicaments",
"description": "Quels symptômes sont associés aux infections résistantes ?\nLes symptômes varient selon l'infection ?\nComment reconnaître une infection grave ?\nLes symptômes peuvent-ils s'aggraver rapidement ?\nY a-t-il des symptômes spécifiques aux bactéries multirésistantes ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Multirésistance aux médicaments",
"description": "Comment prévenir la multirésistance ?\nLe lavage des mains aide-t-il à prévenir ?\nLes vaccinations peuvent-elles aider ?\nQuelles pratiques hospitalières sont importantes ?\nL'éducation des patients est-elle nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Multirésistance aux médicaments",
"description": "Quels traitements sont efficaces contre la multirésistance ?\nPeut-on utiliser des antibiotiques alternatifs ?\nComment gérer une infection multirésistante ?\nLes traitements varient-ils selon l'agent pathogène ?\nLes traitements préventifs existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Multirésistance aux médicaments",
"description": "Quelles complications peuvent survenir ?\nLa multirésistance augmente-t-elle la mortalité ?\nY a-t-il des complications à long terme ?\nLes complications varient-elles selon l'infection ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Multirésistance aux médicaments",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes soins de santé à domicile sont-ils un risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes maladies chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D018432#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la multirésistance ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont effectués sur des échantillons de culture."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la résistance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de diffusion en milieu solide et les tests de dilution en milieu liquide sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une multirésistance ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection persistante malgré un traitement approprié peut indiquer une multirésistance."
}
},
{
"@type": "Question",
"name": "Peut-on identifier les souches résistantes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des méthodes moléculaires comme la PCR peuvent identifier les souches résistantes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme détermine la sensibilité des bactéries aux antibiotiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections résistantes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre persistante, douleurs, et signes d'infection localisée sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon l'infection ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type d'infection et de l'agent pathogène impliqué."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection grave ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des difficultés respiratoires ou une confusion mentale peuvent indiquer une gravité."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections multirésistantes peuvent se détériorer rapidement sans traitement efficace."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux bactéries multirésistantes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement similaires à ceux des infections non résistantes."
}
},
{
"@type": "Question",
"name": "Comment prévenir la multirésistance ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prudente des antibiotiques et des mesures d'hygiène strictes sont essentielles."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le lavage des mains régulier réduit la transmission des infections résistantes."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir certaines infections, réduisant ainsi le besoin d'antibiotiques."
}
},
{
"@type": "Question",
"name": "Quelles pratiques hospitalières sont importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le contrôle des infections et l'isolement des patients infectés sont cruciaux en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle nécessaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur l'utilisation appropriée des antibiotiques est essentielle."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre la multirésistance ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques de dernière génération ou des combinaisons d'antibiotiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antibiotiques alternatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques non conventionnels ou des thérapies ciblées peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Comment gérer une infection multirésistante ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical étroit et des ajustements de traitement sont essentiels pour gérer l'infection."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'agent pathogène ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choix du traitement dépend de l'agent pathogène et de son profil de résistance."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements prophylactiques peuvent être envisagés pour les patients à risque élevé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections prolongées, des septicémies et des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "La multirésistance augmente-t-elle la mortalité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections multirésistantes sont associées à un risque accru de mortalité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des problèmes de santé chroniques et des récidives."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications dépendent du type d'infection et de l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite souvent des soins intensifs et des traitements spécialisés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation excessive d'antibiotiques, l'hospitalisation prolongée et les maladies chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus susceptibles de développer des infections résistantes."
}
},
{
"@type": "Question",
"name": "Les soins de santé à domicile sont-ils un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins inappropriés à domicile peuvent favoriser la résistance aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions avec une forte résistance peut exposer à des souches résistantes."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de maladies chroniques sont plus vulnérables aux infections multirésistantes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/01/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA; Grupo de Parasitología Veterinaria, Universidad Nacional de Colombia, Colombia. Electronic address: pdj38559@uga.edu.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions Program, University of Calgary, Alberta, Canada.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Laboratory Medicine Program, Department of Laboratory Hematology, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Laboratory Medicine Program, Department of Laboratory Hematology, University Health Network, Toronto, ON M5G 2C4, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Human Pathology in Adulthood and Childhood, University of Messina, 98125 Messina, Italy.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Human Pathology in Adulthood and Childhood, University of Messina, 98125 Messina, Italy.
Publications dans "Multirésistance aux médicaments" :
2 publications dans cette catégorie
Affiliations :
The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; Tianjin Key Laboratory of Cellular Homeostasis and Human Diseases; Department of Physiology and Pathophysiology, School of Basic Medical Science, Tianjin Medical University, Heping, Tianjin, 300070, China.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, College of Science, University of Al-Qadisiyah, Diwaniyah, Iraq.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Science, School of Nursing, University of Al-Qadisiyah, Diwaniyah, Iraq.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I", 300645 Timisoara, Romania.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I", 300645 Timisoara, Romania.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Animal Production Engineering, Faculty of Bioengineering of Animal Recourses, University of Life Science "King Mihai I", 300645 Timișoara, Romania.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I", 300645 Timisoara, Romania.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I", 300645 Timisoara, Romania.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Pirogov Russian National Research Medical University, Moscow, Russia.
Publications dans "Multirésistance aux médicaments" :
1 publication dans cette catégorie
Affiliations :
Pirogov Russian National Research Medical University, Moscow, Russia.
Publications dans "Multirésistance aux médicaments" :
Isoniazid and rifampin are the first -line drugs against Mycobacterium tuberculosis. Resistance to these important drugs is a serious threat to human public health. Therefore, this study aimed at mole...
In this descriptive cross-sectional study, 111 non - duplicated clinical samples including sputum and Bronchoalveolar lavage (BAL) samples were collected from patients referred to the Ardabil Health C...
of 111 specimens, 15.3% belonged to NTM. In total, the resistance rate to isoniazid and rifampin was 17% and 27% respectively while the resistance rate to isoniazid and rifampin among NTM was 61.54% a...
In our study, the prevalence of resistance to isoniazid and rifampin among Mycobacterium tuberculosis complex(MTC) and non-tuberculous mycobacteria(NTM) was investigated using the MAS-PCR method. This...
The study evaluated sub-microscopic malaria infections in pregnancy using two malaria Rapid Diagnostic Tests (mRDTs), microscopy and RT-PCR and characterized Plasmodium falciparum dihydrofolate reduct...
This was a cross sectional survey of 121 pregnant women. Participants were finger pricked, blood drops were collected for rapid diagnosis with P. falciparum histidine-rich protein 11 rapid diagnostic ...
Out of one hundred and twenty-one pregnant women sampled, the SD Bioline™ Malaria Ag P.f HRP2-based malaria rapid diagnostic test (mRDT) detected eight (0.06%) cases, the ultra-sensitive Alere™ malari...
IMB5036 is a pyridazinone compound with antiproliferative and antitumour activity against hepatoma and pancreatic cancer. In this study, we attempted to identify the target protein of IMB5036 and test...
We examined the effects of IMB5036 on cancer cells by in vitro assays, a molecular docking model and in vivo tumour models. We performed pull-down experiments using biotinylated IMB5036 and identified...
IMB5036 could overcome resistance to multiple chemotherapeutic drugs at the cellular level and in vivo. Furthermore, IMB5036 was not a P-glycoprotein (P-gp) substrate and downregulated the expression ...
We found IMB5036 binds to KSRP and overcomes multidrug resistance via gasdermin E (GSDME)-dependent pyroptosis....
Multi-drug combinations to treat bacterial populations are at the forefront of approaches for infection control and prevention of antibiotic resistance. Although the evolution of antibiotic resistance...
A major obstacle to chemotherapeutic success in cancer treatment is the development of drug resistance. This occurs when a tumour fails to reduce in size after treatment or when there is clinical rela...
Drug-resistant tuberculosis (DR-TB) in children is a growing global health concern, This review provides an overview of the current epidemiology of childhood TB and DR-TB, including prevalence, incide...
This review discusses the application of nanoliposomes containing siRNA/drug to overcome multidrug resistance for all types of cancer treatments. As drug resistance-associated factors are overexpresse...
Menthol exerts relaxing, antibacterial, and anti-inflammatory activities, and is marketed as a functional food and therapeutic drug....
In the present study, the effects of menthol on the expression of multidrug resistance associated protein 2 (MRP2) and its association with the cytotoxicity of epirubicin (EPI) and cisplatin (CIS) wer...
The expression levels of target genes were examined by real-time PCR. The intracellular concentration of incorporated EPI was measured by high-performance liquid chromatography. Cell viability was eva...
The expression of MRP2 mRNA was increased by exposing HepG2 cells to menthol for 24 hr. Consistent with a previous report suggesting an inverse correlation between MRP2 and Akt behavior, increased exp...
These results demonstrate that menthol causes hepatocellular carcinoma to acquire resistance to anticancer drugs such as EPI and CIS by MRP2 induction....
Antimicrobial resistance is presently one of the greatest threats to public health. The excessive and indiscriminate use of antibiotics imposes a continuous selective pressure that triggers the emerge...
Acquired drug resistance is a major problem in the treatment of cancer. hTERT-immortalized, untransformed RPE-1 cells can acquire resistance to Taxol by derepressing the ABCB1 gene, encoding for the m...